SIFI is a 71-year old, privately owned pharmaceutical company specialised in ophthalmology. The company has three main business units: Pharma, Surgical, Diagnostic. More
SIRS-Lab produces molecular diagnostic systems to identify life-threatening infections. The main objective is early and targeted antibiotic therapy of sepsis, the leading cause of death in hospitals. More
The company is specialised in the development of immunological reagents (monoclonal antibodies) against biochemical markers of disease, and to use these reagents for development of laboratory tests More